UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $4.0M of United Therapeutics Corporation
Sold$4,029,076
$485.43Price
8,300Shares
−18%Stake
What UTHR did after the filing
- The stock from Mon, Jan 5 open, $496.96
- −4.2%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Feb 18 close.
Traded Fri, Jan 2. Filed Fri, Jan 2, 4:30 PM ET, after the close. Returns use the Jan 5 open and the Feb 18 close. Not investment advice.